These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 21593569)
1. Cholinesterase inhibitors improve both memory and complex learning in aged beagle dogs. Araujo JA; Greig NH; Ingram DK; Sandin J; de Rivera C; Milgram NW J Alzheimers Dis; 2011; 26(1):143-55. PubMed ID: 21593569 [TBL] [Abstract][Full Text] [Related]
2. Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer's disease. Dong H; Csernansky CA; Martin MV; Bertchume A; Vallera D; Csernansky JG Psychopharmacology (Berl); 2005 Aug; 181(1):145-52. PubMed ID: 15778881 [TBL] [Abstract][Full Text] [Related]
3. The role of nicotinic receptors in the amelioration of cholinesterase inhibitors in scopolamine-induced memory deficits. Masuoka T; Kamei C Psychopharmacology (Berl); 2009 Oct; 206(2):259-65. PubMed ID: 19639304 [TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics of cholinesterase inhibitors suggests add-on therapy with a low-dose carbamylating inhibitor in patients on long-term treatment with rapidly reversible inhibitors. Darreh-Shori T; Hosseini SM; Nordberg A J Alzheimers Dis; 2014; 39(2):423-40. PubMed ID: 24217282 [TBL] [Abstract][Full Text] [Related]
5. Further evidence for the cholinergic hypothesis of aging and dementia from the canine model of aging. Araujo JA; Studzinski CM; Milgram NW Prog Neuropsychopharmacol Biol Psychiatry; 2005 Mar; 29(3):411-22. PubMed ID: 15795050 [TBL] [Abstract][Full Text] [Related]
6. Effects of Gossypium herbaceam extract administration on the learning and memory function in the naturally aged rats: neuronal niche improvement. Liu Y; Aisa HA; Ji C; Yang N; Zhu H; Zuo P J Alzheimers Dis; 2012; 31(1):101-111. PubMed ID: 22504317 [TBL] [Abstract][Full Text] [Related]
7. Two novel 5-HT6 receptor antagonists ameliorate scopolamine-induced memory deficits in the object recognition and object location tasks in Wistar rats. de Bruin NM; Prickaerts J; van Loevezijn A; Venhorst J; de Groote L; Houba P; Reneerkens O; Akkerman S; Kruse CG Neurobiol Learn Mem; 2011 Sep; 96(2):392-402. PubMed ID: 21757018 [TBL] [Abstract][Full Text] [Related]
8. Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine. Nagakura A; Shitaka Y; Yarimizu J; Matsuoka N Eur J Pharmacol; 2013 Mar; 703(1-3):53-61. PubMed ID: 23276665 [TBL] [Abstract][Full Text] [Related]
9. Dose-specific effects of scopolamine on canine cognition: impairment of visuospatial memory, but not visuospatial discrimination. Araujo JA; Chan AD; Winka LL; Seymour PA; Milgram NW Psychopharmacology (Berl); 2004 Aug; 175(1):92-8. PubMed ID: 15029470 [TBL] [Abstract][Full Text] [Related]
10. Specific impairments in visuospatial working and short-term memory following low-dose scopolamine challenge in healthy older adults. Thomas E; Snyder PJ; Pietrzak RH; Jackson CE; Bednar M; Maruff P Neuropsychologia; 2008 Aug; 46(10):2476-84. PubMed ID: 18514746 [TBL] [Abstract][Full Text] [Related]
11. Cholinesterase inhibitors, donepezil and rivastigmine, attenuate spatial memory and cognitive flexibility impairment induced by acute ethanol in the Barnes maze task in rats. Gawel K; Labuz K; Gibula-Bruzda E; Jenda M; Marszalek-Grabska M; Filarowska J; Silberring J; Kotlinska JH Naunyn Schmiedebergs Arch Pharmacol; 2016 Oct; 389(10):1059-71. PubMed ID: 27376896 [TBL] [Abstract][Full Text] [Related]
12. Does the cholinesterase inhibitor, donepezil, benefit both declarative and non-declarative processes in mild to moderate Alzheimer's disease? Winstein CJ; Bentzen KR; Boyd L; Schneider LS Curr Alzheimer Res; 2007 Jul; 4(3):273-6. PubMed ID: 17627484 [TBL] [Abstract][Full Text] [Related]
13. Donepezil in a chronic drug user--a potential treatment? Jovanovski D; Zakzanis KK Hum Psychopharmacol; 2003 Oct; 18(7):561-4. PubMed ID: 14533139 [TBL] [Abstract][Full Text] [Related]
15. A computer-automated touchscreen paired-associates learning (PAL) task for mice: impairments following administration of scopolamine or dicyclomine and improvements following donepezil. Bartko SJ; Vendrell I; Saksida LM; Bussey TJ Psychopharmacology (Berl); 2011 Mar; 214(2):537-48. PubMed ID: 21086119 [TBL] [Abstract][Full Text] [Related]
16. The selective positive allosteric M1 muscarinic receptor modulator PQCA attenuates learning and memory deficits in the Tg2576 Alzheimer's disease mouse model. Puri V; Wang X; Vardigan JD; Kuduk SD; Uslaner JM Behav Brain Res; 2015; 287():96-9. PubMed ID: 25800972 [TBL] [Abstract][Full Text] [Related]
17. Donepezil, a centrally acting acetylcholinesterase inhibitor, alleviates learning deficits in hypocholinergic models in rats. Ogura H; Kosasa T; Kuriya Y; Yamanishi Y Methods Find Exp Clin Pharmacol; 2000 Mar; 22(2):89-95. PubMed ID: 10849891 [TBL] [Abstract][Full Text] [Related]
18. Donepezil reverses a mnemonic deficit produced by scopolamine but not by perforant path lesion or transient cerebral ischaemia. Higgins GA; Enderlin M; Fimbel R; Haman M; Grottick AJ; Soriano M; Richards JG; Kemp JA; Gill R Eur J Neurosci; 2002 Jun; 15(11):1827-40. PubMed ID: 12081663 [TBL] [Abstract][Full Text] [Related]